© 2021 BioMarin. All rights reserved.

BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- Jefferies Virtual Healthcare Conference on June 3 at 1:00pm ET
- Goldman Sachs 42nd Annual Global Healthcare Conference on June 9 at 4:40pm ET
May 27, 2021

SAN RAFAEL, Calif., May 27, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors                                              

Media

Traci McCarty                                       

Debra Charlesworth

BioMarin Pharmaceutical Inc.                 

BioMarin Pharmaceutical Inc.

(415) 455-7558                                        

(415) 455-7451

 

SOURCE BioMarin Pharmaceutical Inc.